Vyvanse (Lisdexamfetamine) is a drug developed by Shire Pharmaceuticals as a successor to Adderall. Vyvanse was first approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 2007. In 2015, Vyvanse was approved for binge eating disorder and was found to successfully minimize appetite and number of binge eating episodes per week compared to a placebo. …
Dexedrine is a psychostimulant drug primarily used to treat severe cases of ADHD and narcolepsy. The active ingredient in Dexedrine is “dextroamphetamine” which is regarded as the “right-handed” stereoisomer of the molecule amphetamine. Dextroamphetamine is considered a popular military stimulant, and has been utilized throughout history such as in World War II to offset fatigue …
Methylphenidate is considered the first medication approved for the treatment of the condition known as “hyperactivity” in the 1960s. As attention-deficit/hyperactivity disorder gained more mainstream attention in the 1990s, the number of diagnoses continued to skyrocket, increasing the demand for new treatments. By the year 1996, mixed amphetamine salts (i.e. Adderall) were approved for the …
Provigil (modafinil) is a drug that was approved in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy. It has since been granted FDA approval for the treatment of obstructive sleep apnea as well as shift work sleep disorder. Adderall (mixed amphetamine salts) is a psychostimulant drug that was initially approved in 1996 …
The pharmaceutical market is saturated with drugs intended to treat ADHD. The number of different options is often helpful for patients that may not respond to the first drug that they try. Although there are a variety of different options, the two most popular formulations are those containing mixed amphetamine salts and those containing methylphenidate. …
An overwhelming majority of medications used to treat ADHD (attention-deficit/hyperactivity disorder) are classified as psychostimulants. Although psychostimulant drugs tend to have an immediate effect in reducing symptoms of attentional deficits and hyperactive behavior, they have a high potential for abuse. Furthermore, there is something to be said for the potential that long-term psychostimulant use may …
Concerta is a medication that was approved in August 2000 for the treatment of ADHD (attention-deficit hyperactivity disorder) in children. Since its initial approval as an ADHD medication for children, it has attained FDA approval for usage in adolescents (2004) and adults (2008) with ADHD. Although Concerta is technically a newer drug than Adderall, the …